Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Susan Stimson
AddedFeb 13, 2024
UpdatedMay 31, 2026
Susan Stimson

Susan Stimson

Board Member, Avelas Biosciences

CrunchbaseLinkedInThe Org

Susan Stimson's Career

Avelas Biosciences
Avelas Biosciences

Los Angeles, CA, US

Board Member· Board
Gynesonics
Gynesonics

Redwood City, CA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Susan Stimson's Career

Avelas Biosciences
Avelas Biosciences
Public$41.9M362008Los Angeles, CA, US
Board Member· Board

Leadership at Avelas Biosciences

Elena StarikovaElena StarikovaBoard Member
Roger TsienRoger TsienFounder
Jay LichterJay LichterBoard Member
Carmine StengoneCarmine StengoneBoard Member
Timothy ScottTimothy ScottBoard Member

Similar to Avelas Biosciences

Blaze BioscienceBlaze BioscienceSeattle, WA, USImaging, Tumor Paintest. 2010Blaze BioscienceSeattle, WA, US · est. 2010

Seattle-based Blaze Bioscience develops tumor paint technology for precise, real-time cancer cell visualization.

Series B · $55.4M38
avelisbiotech.comavelisbiotech.comScottsdale, AZ, USTechnologyest. 2007avelisbiotech.comScottsdale, AZ, US · est. 2007

Avelis LLC: Innovating natural enhancement technologies for plants, water, and animals since 2007.

Seed · $250k6
Vergent BioscienceVergent BioscienceMinneapolis, MN, USImaging Agentsest. 2016Vergent BioscienceMinneapolis, MN, US · est. 2016

Vergent Bioscience: Pioneering in tumor-targeted molecular imaging for cancer surgery.

Series B · $34.4M13
Gynesonics
Gynesonics
Public$401.8M1392005Redwood City, CA, US
Board Member· Board

Leadership at Gynesonics

David PacittiDavid PacittiBoard Member
Bali MuralidharBali MuralidharBoard Member
Jonathan MacQuittyJonathan MacQuittyBoard Member
Doug FisherDoug FisherBoard Member
Tom RodgersTom RodgersBoard Member
Jessica GrossmanJessica GrossmanFounder

Similar to Gynesonics

Minerva SurgicalMinerva SurgicalSanta Clara, CA, USMedical Devicesest. 2008Minerva SurgicalSanta Clara, CA, US · est. 2008

US-based Minerva offers a comprehensive suite of devices for minimally invasive treatment of Abnormal Uterine Bleeding.

Public · $173.9M189
Mirabilis MedicaMirabilis MedicaBothell, WA, USMedical Devicesest. 2006Mirabilis MedicaBothell, WA, US · est. 2006

Mirabilis Medica designs therapeutic ultrasound devices for uterine fibroids treatment in the US.

Angel · $29.1M8
FemasysFemasysSuwanee, GA, USMedical Devicesest. 2004FemasysSuwanee, GA, US · est. 2004

Femasys: Innovating women's healthcare through R&D and manufacturing of medical devices.

Public · $70.8M34
PharmasonicsPharmasonicsSunnyvale, CA, USMedical Devicesest. 1995PharmasonicsSunnyvale, CA, US · est. 1995

Innovative medical tech company in Sunnyvale, CA.

Series A · $6.1M30

Susan Stimson's Similar Executives & Operators

Lau Eng BoonLau Eng BoonBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoSean JohSean JohBoard Member · Kakao

People Similar to Susan Stimson

Chris OwensChris OwensBoard Member · Amphora MedicalJay WangJay WangCo-Founder · ZenomicsPanos MoutafisPanos MoutafisBoard Member · ZenusWannie ParkWannie ParkCEO · Zen EcosystemsDave StewartDave StewartFounder & CEO · Zen EnterprisesDaniel J.Daniel J.Co-Founder · Zen